Co-Diagnostics (CODX) Tops Q1 EPS by 17c

Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of $0.34, $0.17 better than the analyst estimate of $0.17. Revenue for the quarter came in at $22.7 million versus the consensus estimate of $20.17 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
• Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue